taxus :
Search Words
News & Articles
- Cardium Enters Strategic Collaboration, Will Change Name
Cardium Therapeutics Inc. has entered a strategic collaboration and funding arrangement with Shanxi Taxus Pharmaceuticals Co. Ltd. of China to support the worldwide clinical and commercial development of San Diego-based Cardium’s regenerative medicine therapeutics products.
March 4, 2014 - San Diego Business Journal - Cardium Gets Strategic Funding From China
San Diego-based Cardium Therapeutics said Monday that it has scored a strategic funding from Shanxi Taxus Pharmaceuticals Co., Ltd., to help support development of its regenerative medicine therapeutics products. According to Cardium, the deal is worth up to $5.0M to support commercialization of its products. The publicly traded company said it will change its name to Taxus Cardium ...
March 4, 2014 - socalTech.com - Cardium Announces Strategic Collaboration And Funding With Taxus Pharmaceuticals To Support Commercial Development Of ...
SAN DIEGO, March 3, 2014 /PRNewswire/ -- Cardium Therapeutics Inc. (Trading Symbol: CRXM) reported that it has entered into a strategic collaboration and funding arrangement with Shanxi Taxus Pharmaceuticals Co., Ltd., which is affiliated with Shenzhen Forntsea Taxus Industry Capital Management, to support the worldwide clinical and commercial development of Cardium's advanced regenerative ...
March 3, 2014 - PR Newswire via Yahoo! Finance
Quotes
- Charles Bryson Simonton in FOXBusiness
At any given point in time, across both the pivotal SPIRIT II and SPIRIT III clinical trials, XIENCE V consistently reduces observed MACE rates by 40 percent or more compared to TAXUS,said Charles Simonton, MD, FACC, FSCAI, divisional vice... - William Hunter in Canada NewsWire (press release)
We are pleased that the innovative technology of the TAXUS Express2 stent is now available to physicians in Japan, offering them another treatment option with proven outcomes across a broad range of patients,said Dr. William Hunter, President... - Philippe Brunel in Medical News Today (press release)
Until now, French patients suffering from coronary artery disease were being denied the TAXUS Liberte Stent system due to the lack of reimbursement,said Dr. Philippe Brunel, interventional cardiologist at the Nouvelles Cliniques Nantaises,...